JP
JAKKS PACIFIC INC (JAKK)·Q1 2024 Earnings Summary
Executive Summary
- Q1 2024 was seasonally small and materially weaker year-over-year: net sales fell 16% to $90.1M and gross margin contracted 580 bps to 23.4% on higher obsolescence and retailer markdowns tied to a disappointing Q4 2023 film release .
- Non-GAAP metrics deteriorated: Adjusted EPS was a loss of $1.09 vs. a $0.40 loss in Q1 2023, and Adjusted EBITDA was $(17.2)M vs. $(1.1)M in Q1 2023 .
- Balance sheet positive catalyst: retirement of preferred shares removed restrictions on capital return; total debt remains zero, cash was $35.5M at quarter end (seasonally low), and inventory declined to $46.3M .
- Management expects margin recovery as one-time cleanup effects subside and back-half content (Moana 2, Sonic 3) plus evergreen lines drive sales; they reiterated confidence that full-year gross margin will “start with a 3” despite Q1 pressure .
What Went Well and What Went Wrong
What Went Well
- “For the first time in many years, there are no lenders or other parties restricting the common stockholders’ claim over the entire enterprise,” after retiring preferred shares at a discount, removing a capital return constraint .
- Strategic pipeline for H2 and 2025: retailers reacted positively to new licenses and evergreen portfolio; Moana 2 and Sonic 3 lines expected on shelf in Q4 with strong engagement in Europe and Latin America .
- Evergreen strength and strategic focus: management emphasized expanding evergreen brands and international distribution, with confidence in a gross margin that “starts with a 3” for the year even though Q1 was weak .
What Went Wrong
- Net sales down 16% to $90.1M; Toys/Consumer Products down 15% and Costumes down 25% year-over-year amid a light film slate and markdowns to clear inventory tied to a Q4 2023 release .
- Gross margin compressed 580 bps to 23.4%; margin headwinds included obsolescence, retailer price promotions, and cleanup of the prior film-driven assortment .
- Operating loss widened to $(21.3)M (vs. $(4.4)M) and G&A rose 22% y/y as management invests in infrastructure, technology, and international capabilities; CFO noted small-quarter dynamics magnified timing and cost effects .
Financial Results
Segment Net Sales (Q1):
Geography Net Sales (Q1):
KPIs and Balance Sheet/CF:
Notes:
- Q1 2024 versus Q4 2023 showed sequential declines in revenue and margins, reflecting seasonal trough and cleanup actions; year-over-year declines were broader across segments/regions, with Europe particularly soft (-44% y/y) .
- Non-GAAP reconciliations and definitions provided in the company’s 8-K exhibits .
Guidance Changes
No quantified revenue/EPS/margin guidance ranges were provided in Q1 materials; commentary emphasized back-half content, evergreen portfolio, and international expansion .
Earnings Call Themes & Trends
Management Commentary
- CEO on seasonality and film slate: “Without that new news in Spring 2024... we experienced lower levels of both [shipping and retail sales] as anticipated. We also continued to see weakening demand for products from a Q4 2023 film release... supported our retail partners in funding markdowns... and addressing cancelled reorders” .
- CFO on margins: “Q1 saw a number of negative impacts... unique to Q1... for the balance of the year... a lot of that... bad news is behind us... we still feel we are running a business that will generate a gross margin percentage that starts with a 3” .
- CEO on capital structure: “For the first time in many years, there are no lenders or other parties restricting the common stockholders’ claim over the entire enterprise... a fantastic starting point” .
- Strategic pipeline: “We are very excited... supporting two of the bigger film releases planned for Q4... traction... new 2025 initiatives... relentless efforts to expand our international network” .
Q&A Highlights
- Limited live Q&A; management addressed emailed questions. Margin unpacking: CFO detailed Q1 one-time impacts and price promotion pressure, with expectation of improvement through the year .
- Product rollout timing: CEO noted ABG skateboards/roller skates targeted for fall 2024; broader outdoor categories in 2025; Simpsons tease in late 2024 with major rollout in 2025 .
- Liquidity and shipping costs: Given FOB-first mix, rising shipping costs were not a top concern; Europe disruptions more relevant to transit times/capacity .
Estimates Context
- Wall Street consensus (S&P Global) for Q1 2024 EPS and revenue was unavailable at time of analysis due to a Capital IQ request limit; therefore, we cannot assess beats/misses versus consensus. Values retrieved from S&P Global were unavailable.
Key Takeaways for Investors
- Q1 2024 was a cleanup quarter with margin compression and markdown support tied to a weak Q4 film release; expect margin normalization as promotional pressure abates and one-time effects roll off .
- Structural de-risking continues: debt-free and preferred shares retired, increasing flexibility for capital allocation (licenses, M&A, potential capital return) while maintaining liquidity through seasonal troughs .
- Back-half setup looks favorable: Moana 2 (Disney) and Sonic 3 (Paramount) plus evergreen franchises set to drive Q4 shelf presence; Simpsons and ABG initiatives extend into 2025, diversifying seasonality and categories .
- International growth is a multiyear lever: expanded EU footprint and strong Latin America momentum (e.g., Mexico) should support distribution and scale; FOB-first model aids working capital efficiency .
- Near-term P&L sensitivity: smaller quarters amplify timing/SG&A effects; investors should monitor Q2 margin progression, inventory health, and retail sell-through trends to gauge trajectory into H2 .
- Segment watch: Action Play & Collectibles has secular momentum tied to gaming/IP; Costumes remains sensitive to film slate; Outdoor/Seasonal repositioning with ABG could mitigate historical volatility .
- With no formal quantitative guidance, focus on execution against back-half content, evergreen placements, and Europe/LATAM distribution to drive FY margins back over 30% per management commentary .